In colorectal cancer, phosphorylated ATF6 has been demonstrated to promote tumor development by inducing gut microbiome dysbiosis and activating the TIR domain-containing adapter-inducing interferon-β (TRIF)/STAT3 signaling cascade [34]. This evidence concerns the gene ATF6 and neoplasm.